Clinical Guides
Aortic Stenosis
A clinically focused clinical guide to recognising and staging aortic stenosis in adults, resolving discordant echocardiography, selecting surveillance or valve intervention through a Heart Team, and applying current international guidance cautiously within India's variable surgical and transcatheter access landscape.
MedNext Academy | 14 min read
Aortic Stenosis
A clinically focused clinical guide to recognising and staging aortic stenosis in adults, resolving discordant echocardiography, selecting surveillance or valve intervention through a Heart Team, and applying current international guidance cautiously within India's variable surgical and transcatheter access landscape.
Summary
Aortic stenosis is fixed obstruction to left-ventricular outflow at the aortic valve. In older adults it is usually calcific; bicuspid anatomy can produce disease earlier, while rheumatic involvement more often accompanies other valve lesions. Progressive narrowing raises left-ventricular pressure, drives concentric hypertrophy and eventually limits cardiac output and coronary perfusion. The classic symptomatic triad is exertional dyspnoea, angina and syncope, but declining exercise, dizziness, heart-failure congestion and unexplained falls may be the presenting language. Symptoms signal urgency only after their relationship to valve severity has been tested.
Diagnosis starts with clinical suspicion and transthoracic echocardiography. Severity is not one number: valve morphology, peak velocity, mean gradient, valve area, indexed flow, ejection fraction, ventricular response and technical quality must agree. Low-flow, low-gradient states require deliberate resolution rather than automatic reclassification as moderate disease. Exercise testing can reveal occult symptoms in selected apparently asymptomatic patients; dobutamine stress echocardiography or CT calcium scoring can help in defined discordant cases. Symptomatic severe stenosis and severe disease with ventricular dysfunction usually require valve-intervention evaluation.
No medicine opens a calcified valve or reliably halts progression. Drugs treat associated hypertension, atrial fibrillation, coronary disease and congestion with careful haemodynamic monitoring. Definitive options are surgical aortic-valve replacement and transcatheter aortic-valve implantation; balloon valvuloplasty has limited bridging or palliative roles. Choice requires a multidisciplinary Heart Team, anatomy, age, frailty, life expectancy, coronary and aortic disease, access route, durability, future procedures, patient preference, local outcomes and affordability. This draft has been reviewed by the MedNext Clinical Team and cannot direct an individual procedure.
How Common Is It?
The burden of calcific aortic stenosis rises sharply with age, so ageing populations produce more detected disease. Mild valve thickening and sclerosis are more common than haemodynamically important stenosis, and a murmur prevalence cannot be equated with severe disease. Bicuspid aortic valve shifts presentation into younger adulthood and may coexist with ascending-aortic enlargement. Rheumatic stenosis remains relevant in India but isolated heavily calcific stenosis in an older person has a different mechanism and procedural anatomy from multivalve rheumatic disease.
Reliable Indian prevalence estimates are difficult to generalise. Community echocardiographic screening is not uniform, referral concentrates severe cases in tertiary hospitals, and surgical or TAVI registries describe treated patients rather than everyone with disease. A hospital case series therefore cannot establish population prevalence or equal access. International estimates may help frame ageing-related burden, but they should not be relabelled as contemporary Indian national data. This guide does not claim a single India percentage for moderate or severe stenosis.
For an individual, prevalence is less useful than pre-test probability and trajectory. An older person with a harsh ejection systolic murmur, reduced second sound, exertional symptoms or abnormal ECG has a different likelihood from an asymptomatic young adult with a soft flow murmur. Progression varies; repeat velocity change can carry prognostic information, but comparison is valid only when acquisition and loading conditions are credible. Population detection programmes must also plan confirmatory echocardiography, specialist review and intervention capacity. Screening without a pathway can increase diagnostic labels without improving outcomes, particularly where travel, cost and valve-centre availability limit completion of care.
Risk Factors
Age-related calcific disease shares associations with atherosclerotic biology, including hypertension, smoking, dyslipidaemia, diabetes and chronic kidney disease, but treating those conditions has not been shown to dissolve established valve obstruction. Congenital bicuspid anatomy is a major substrate for earlier stenosis and warrants assessment of the aortic root and ascending aorta. Previous chest radiotherapy, familial calcific valve disease, metabolic bone-mineral disturbance in advanced kidney disease and some rare lipid or storage disorders can accelerate presentation. Rheumatic disease should be considered when there is commissural fusion or accompanying mitral involvement.
Risk of adverse outcome is not identical to risk of developing stenosis. Once severe disease is present, symptoms, left-ventricular systolic dysfunction, very high jet velocity, rapid haemodynamic progression, markedly elevated natriuretic peptide, abnormal exercise response, pulmonary hypertension, low flow, myocardial fibrosis and associated coronary disease may influence timing. Each marker has measurement and context limitations. BNP varies with age, renal function, rhythm and other cardiac disease; apparent velocity progression can reflect different Doppler alignment or blood pressure.
Procedural risk also requires a separate assessment. Frailty, cognitive status, mobility, chronic lung or kidney disease, anaemia, bleeding risk, porcelain aorta, prior chest surgery, vascular calibre, coronary anatomy, bicuspid morphology, annular dimensions and the need for other valve or aortic surgery shape the option. Surgical risk scores support but do not replace judgement because disability and anatomy may be underrepresented. Younger patients need lifetime planning for durability, coronary access and possible reintervention. Older patients need realistic benefit assessment rather than denial based on chronological age. Patient goals, caregiver support, rehabilitation access and the centre's audited results belong in risk discussion.
Diagnosis
History
Ask about exertional breathlessness, chest pressure, presyncope or syncope, reduced walking distance, slowing on stairs, orthopnoea, oedema, fatigue and falls. Establish onset, trajectory and activity adaptation; a person who says they are asymptomatic may have stopped exerting. Clarify whether syncope occurred during exertion and screen for arrhythmia, orthostatic, neurological and medication explanations. Record coronary risk, kidney disease, rheumatic fever, chest radiation, congenital valve history, family aortopathy, prior echocardiograms, dental infection and future pregnancy wishes. Functional history should be specific enough to compare at follow-up.
Examination
Measure pulse, blood pressure and volume status. Classic severe findings include a slow-rising low-volume carotid pulse, narrow pulse pressure, a sustained displaced apex, a harsh late-peaking ejection systolic murmur radiating to the carotids and a soft or absent aortic component of the second sound. Findings vary with flow, age, hypertension, obesity and lung disease; a quiet murmur can occur in low-output severe stenosis. Look for heart failure, other murmurs and an irregular rhythm. Exertional syncope plus a systolic murmur warrants urgent assessment rather than provocative bedside exercise.
Investigations
Transthoracic echocardiography assesses morphology, left-ventricular function, peak jet velocity, mean gradient, valve area, flow, other valves and aorta. Severe high-gradient stenosis typically aligns at Vmax at least 4.0 m/s, mean gradient at least 40 mmHg and valve area no more than 1.0 cm2, but discordance demands review of measurements and physiology. ECG may show hypertrophy or conduction disease; chest radiography is not diagnostic. In low-flow low-gradient disease with reduced ejection fraction, dobutamine stress echo tests true severity and contractile response. CT calcium scoring assists selected uncertain cases; CT also plans TAVI. Exercise testing is reserved for supervised assessment of apparently asymptomatic severe disease. Coronary evaluation follows planned intervention and individual probability.
Differential Diagnosis
The murmur must be distinguished from aortic sclerosis without important obstruction, a high-flow murmur, hypertrophic obstructive cardiomyopathy and subvalvular or supravalvular stenosis. Aortic sclerosis usually retains a normal carotid upstroke and does not create a severe Doppler gradient. Hypertrophic obstruction often changes with loading manoeuvres and has different echocardiographic anatomy. A murmur at the right upper sternal border can also reflect transmitted vascular sound. Echocardiography resolves most structural uncertainty, but poor windows, Doppler misalignment and irregular rhythm can create false reassurance or overestimation.
Symptoms require their own differential. Exertional chest discomfort may be coronary disease; dyspnoea may arise from lung disease, anaemia, obesity, deconditioning, heart failure with another cause or mitral valve disease. Syncope may be arrhythmic, orthostatic, reflex or neurological. Severe stenosis can coexist with these conditions, so finding valve disease does not prove attribution. If symptoms appear disproportionate to measured stenosis, recheck echo quality, flow and alternative disease rather than forcing concordance.
Discordant severe-stenosis patterns are a diagnostic category, not a final answer. Reduced-ejection-fraction low-flow low-gradient stenosis may represent truly severe fixed obstruction or pseudo-severe opening limitation from weak flow. Paradoxical low-flow severe stenosis can occur despite preserved ejection fraction and needs confirmation of stroke-volume index, blood pressure and measurement accuracy. Normal-flow low-gradient disease also merits review. CT calcium, stress echo and expert imaging may be appropriate, but thresholds depend on sex, method and guidance. Mixed aortic stenosis and regurgitation, bicuspid aortopathy and multivalve rheumatic disease require integrated assessment rather than isolated valve-area arithmetic.
Management
Mild or moderate disease is managed through education, cardiovascular risk care and surveillance matched to severity and change. People should know which symptoms to report promptly and should not avoid all activity automatically. Repeat echocardiography intervals depend on severity, progression, symptoms and specialist judgement; a technically discordant baseline should be resolved before assigning years of follow-up. Apparently asymptomatic severe disease needs specialist review, often at least six- to twelve-month clinical and echocardiographic reassessment when intervention is not yet selected. Supervised exercise testing can reveal symptoms in suitable patients but is not performed in symptomatic severe stenosis.
Valve replacement is the definitive therapy. Symptomatic severe aortic stenosis and severe stenosis with left-ventricular systolic dysfunction are established intervention pathways. Very severe obstruction, abnormal exercise response, rapid progression, elevated BNP or other high-risk features may support earlier intervention in selected asymptomatic patients. The 2025 ESC/EACTS update expands consideration of intervention and refines TAVI versus surgery selection, but its recommendations require jurisdictional, anatomical and centre-level interpretation. A guide should not turn an age threshold into an automatic procedure.
Surgical replacement may suit younger patients, bicuspid valves, unsuitable transfemoral anatomy, concomitant coronary bypass, ascending-aortic surgery or another valve operation. TAVI can reduce surgical trauma and recovery time for anatomically suitable patients, but introduces vascular injury, paravalvular leak, conduction block or pacemaker, coronary-access and durability considerations. Heart Team discussion integrates life expectancy, frailty, anatomy, access route, prosthesis choice, future valve-in-valve feasibility, local outcomes, affordability and preference. Balloon valvuloplasty usually restenoses and is reserved for carefully selected bridging, diagnostic or palliative situations. Futility must be considered when severe non-cardiac disease makes meaningful recovery unlikely.
Prescribing Information
No drug has been proved to reverse calcific aortic stenosis or replace indicated valve intervention. Statins are prescribed for established lipid and vascular indications, not to open the valve. Treat hypertension because uncontrolled afterload is harmful and distorts assessment, but start or adjust agents thoughtfully in severe disease and monitor pressure, renal function and symptoms. Angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers and other antihypertensives are not universally forbidden; individual haemodynamics, comorbidity and supervision matter more than an obsolete blanket contraindication.
Diuretics may relieve pulmonary or peripheral congestion, yet excessive preload reduction can cause hypotension or low output. Nitrates and vasodilators require context and monitoring, especially in acute care. Beta-blockers may be indicated for coronary disease or rate control but can worsen bradycardia or low output in selected patients. Atrial fibrillation requires stroke-risk assessment and rate or rhythm strategy; anticoagulation follows the valve type, rhythm and current guidance. Native aortic stenosis alone is not an indication for anticoagulation, antiplatelet treatment or antibiotic prophylaxis.
After valve replacement, prescribing depends on a mechanical versus biological prosthesis, TAVI versus surgery, atrial fibrillation, coronary intervention and bleeding risk. Mechanical valves require vitamin-K-antagonist management with a valve-specific INR target; direct oral anticoagulants are not substitutes for a mechanical prosthesis. Antithrombotic practice after TAVI evolves with evidence and must follow the implanting team's current protocol. Reconcile over-the-counter NSAIDs, herbal products and duplicate antiplatelets. Endocarditis prevention centres on oral health and guideline-defined antibiotic prophylaxis for high-risk prosthetic-valve situations, not routine antibiotics for every murmur. This section teaches verification and adverse-effect awareness; it does not supply a patient-specific regimen.
When to Refer
Offer echocardiography when a systolic murmur suggests valve disease and the person has breathlessness, angina, oedema, abnormal ECG or a reduced second heart sound. Even without symptoms, age, family history, bicuspid features and murmur character can justify imaging. Once echocardiography shows moderate or severe aortic stenosis, specialist cardiology referral is appropriate. Bicuspid valve disease also needs assessment of the ascending aorta and often family or congenital-cardiology considerations. A referral should include functional capacity, symptom timing, blood pressure, rhythm, comorbidities, previous measurements and the complete echo report, not only valve area.
Urgent assessment is required when a systolic murmur accompanies exertional syncope, severe breathlessness at minimal activity or rest, escalating angina, acute heart failure or hypotension. If severe stenosis is already known, new symptoms should trigger prompt valve-team contact. Do not reassure from a preserved ejection fraction or schedule a distant routine review without reconciling the clinical change. Conversely, non-exertional syncope still needs a broad urgent pathway because an arrhythmia or neurological cause may coexist.
Refer severe disease to a centre capable of multidisciplinary valve assessment when intervention is possible. The team should include imaging, interventional cardiology, cardiac surgery, anaesthesia and other expertise as needed. Early referral allows CT planning, coronary assessment, dental and infection review, frailty evaluation, shared decision-making and financial counselling before decompensation. In India, the receiving pathway may be a government institute, teaching hospital, empanelled centre or private valve programme; verify availability, eligibility, waiting time and postoperative follow-up. Referral does not guarantee candidacy and should not promise TAVI or surgery before anatomical and benefit assessment.
Red Flags
Exertional syncope with a systolic murmur is a high-risk presentation requiring urgent specialist assessment and echocardiography. Severe breathlessness at rest, pulmonary oedema, persistent chest pain, hypotension, new confusion, cool peripheries or oliguria can indicate decompensation and need emergency care. A quiet murmur does not exclude critical stenosis when cardiac output is low. New atrial fibrillation, ventricular arrhythmia, high-grade conduction block or recurrent unexplained falls can destabilise a patient with limited outflow reserve.
Suspect infective endocarditis when fever, embolic features, new regurgitation, persistent bacteraemia or prosthetic-valve dysfunction accompanies valve disease. Obtain appropriate cultures before antibiotics when clinically safe, but do not delay sepsis management. Sudden tearing chest or back pain, pulse asymmetry or neurological deficit raises aortic dissection, particularly with bicuspid aortopathy, and follows an emergency aortic pathway rather than routine stenosis management. Acute coronary syndrome remains a parallel emergency diagnosis in a patient with angina.
After TAVI or surgery, red flags include sudden dyspnoea, syncope, stroke symptoms, limb ischaemia, expanding access-site swelling, major bleeding, fever, new murmur, heart failure, haemolysis or bradycardia. Mechanical-valve patients with interrupted anticoagulation or abnormal valve sounds need urgent assessment for thrombosis. Structural-valve deterioration is usually later but must be considered when gradients rise or symptoms recur. For patients being observed, worsening exercise tolerance is not a benign ageing symptom until reviewed. Pregnancy with severe stenosis creates substantial maternal risk and needs specialist preconception or urgent cardio-obstetric input rather than routine antenatal management.
Indian Clinical Context
India combines a large ageing population with congenital bicuspid disease, rheumatic multivalve pathology and highly variable access to echocardiography, cardiac surgery and TAVI. Published tertiary-centre experience is valuable for procedural practice but does not establish national prevalence, waiting time, affordability or outcomes. Public, insurance-funded and self-pay pathways use different eligibility and procurement arrangements. A clinical plan must name the actual centre, expected timing, financing route, travel, caregiver needs, rehabilitation and access to emergency review rather than assume a uniform valve network.
International guidance supplies a strong evidence framework but is not an Indian legal or commissioning protocol. current guidelines recommendations include UK cost-effectiveness assumptions and were under review for TAVI in 2025; those conclusions cannot simply determine Indian modality. The 2025 ESC/EACTS update and 2020 ACC/AHA guidance use different age and lifetime-planning frameworks. In India, the Heart Team should consider anatomy, audited local outcomes, device availability, surgical capacity, patient longevity, reintervention options and preference. Cost pressure must not be disguised as a clinical contraindication, and technology marketing must not replace balanced consent.
Echo quality is an access issue as well as a technical issue. Discordant values may justify repeat imaging at an experienced laboratory before an expensive procedure is accepted or denied. CT planning requires contrast and radiation assessment; coronary angiography strategies vary. Mechanical prostheses create lifelong INR and pregnancy implications, while tissue valves raise durability and future access questions. Dental review, infection prevention, anticoagulation continuity and postprocedure echo must be feasible after discharge. Where definitive intervention cannot occur promptly, symptom management and safety-netting are necessary, but balloon valvuloplasty or medicines should not be presented as equivalent durable treatment.
NMC Competency Mapping
Aortic stenosis fits the undergraduate internal-medicine competencies on heart failure and valvular disease. IM1.10 and IM1.11 require a structured cardiovascular history and systematic examination. IM1.12 to IM1.15 address pulse, blood pressure, jugular venous assessment, heart sounds and murmurs. IM1.17 to IM1.20 cover selection and interpretation of ECG, radiography, echocardiography, biomarkers, exercise testing and coronary evaluation, followed by severity determination and the level of intervention. IM1.25 includes indications for valve procedures and related cardiac intervention.
A competent learner should recognise the slow-rising pulse, ejection systolic murmur with carotid radiation and reduced second sound while knowing that signs lose sensitivity in low flow or difficult examination. They should connect exertional dyspnoea, angina and syncope with haemodynamics without assuming causality. Echo interpretation must integrate Vmax, mean gradient, valve area, flow and ejection fraction, then identify discordance requiring expert review. Reading a report does not certify independent echocardiography, exercise testing or dobutamine-stress interpretation.
Management competence means explaining surveillance, recognising an intervention indication, treating associated conditions safely and communicating procedural trade-offs. Students should compare TAVI and surgery through anatomy, durability, access, concomitant disease and patient preference rather than a memorised age cutoff. They should identify acute heart failure, syncope, endocarditis and aortic dissection red flags. Shared decision-making includes affordability and follow-up without lowering the clinical standard. These outcomes support supervised bedside and case-based learning; they do not authorize independent prescribing, procedural consent or valve-team selection.
Key Exam Pearls for NEET PG
Calcific degeneration is the usual mechanism in older adults; bicuspid valve causes earlier disease, while rheumatic stenosis commonly accompanies other valve lesions. Chronic pressure overload produces concentric left-ventricular hypertrophy and reduced coronary reserve. The classic features are angina, syncope and dyspnoea. Examination shows pulsus parvus et tardus, narrow pulse pressure, a heaving apex, a harsh crescendo-decrescendo ejection systolic murmur radiating to the carotids and a soft A2. In low-output disease, murmur intensity can fall, so a soft murmur does not mean mild obstruction.
Echo defines anatomy and haemodynamics. High-gradient severe stenosis is typically Vmax at least 4 m/s, mean gradient at least 40 mmHg and valve area at most 1.0 cm2. Check Doppler alignment, LV outflow-tract measurement, rhythm, blood pressure and flow when values disagree. Reduced-EF low-flow low-gradient disease may need dobutamine stress echo; selected uncertain cases may need CT calcium scoring. Exercise testing can unmask symptoms only in apparently asymptomatic severe disease under supervision and is inappropriate when the patient is already symptomatic.
Symptoms or left-ventricular systolic dysfunction in severe stenosis are major indications for valve intervention. No drug reverses valve calcification. SAVR and TAVI choice belongs to a Heart Team and includes age, life expectancy, bicuspid anatomy, vascular access, coronary or aortic surgery need, durability and preference. Balloon valvuloplasty is generally a bridge, not a durable cure. Mechanical prostheses need vitamin-K-antagonist anticoagulation; direct oral anticoagulants are not used for a mechanical valve. Exertional syncope with a murmur, pulmonary oedema, hypotension and postoperative conduction or vascular complications are urgent.
Frequently Asked Questions
Can severe aortic stenosis be present with a quiet murmur?
Yes. Murmur intensity depends on flow as well as narrowing. In low-output severe stenosis, especially with ventricular dysfunction, little flow may cross the valve and the murmur can be softer than expected. Symptoms, pulse, second heart sound and complete echocardiographic assessment matter more than loudness alone.
Do statins or other medicines stop calcific aortic stenosis progressing?
No medicine has been shown to open a calcified valve or replace indicated intervention. Statins, antihypertensives, diuretics and rhythm treatments may be appropriate for coexisting cardiovascular conditions or congestion, but their indication and monitoring are separate from treatment of the fixed obstruction.
Is TAVI automatically better than surgery because it is less invasive?
No. TAVI can shorten recovery and avoid sternotomy, but vascular access, bicuspid anatomy, coronary access, pacemaker risk, leak, durability and future procedures matter. Surgery may be preferable for younger patients or when coronary, aortic or other valve surgery is needed. A Heart Team should individualise the choice.
What should happen when valve area suggests severe stenosis but the gradient is low?
First verify the measurements, blood pressure, rhythm and stroke flow rather than averaging the disagreement. Low-flow states may require expert repeat imaging, dobutamine stress echocardiography when ejection fraction is reduced, or selected CT calcium scoring. Symptoms and ventricular response are integrated before intervention is decided.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic